1. |
Wang Y, Lin L, Ji Y, et al. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection. Ann Palliat Med, 2020, 9(3): 721-729.
|
2. |
Oronsky B, Reid TR, Oronsky A, et al. What's new in SCLC? A review. Neoplasia, 2017, 19(10): 842-847.
|
3. |
Sodja E, Rijavec M, Koren A, et al. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer. Radiol Oncol, 2016, 50(2): 188-196.
|
4. |
Salgia R, Weaver RW, McCleod M, et al. Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: Exploratory analysis of a phaseⅡstudy. Invest New Drugs, 2017, 35(3): 334-344.
|
5. |
Lu Y, Jiang J, Ren C. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis. PLoS One, 2020, 15(4): e0230979.
|
6. |
Yang HB, Xing M, Ma LN, et al. Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: A meta-analysis. Oncotarget, 2016, 7(47): 76769-76778.
|
7. |
Li W, Ma G, Wu Q, et al. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: A systematic review and meta-analysis. Oncotarget, 2017, 8(66): 110606-110613.
|
8. |
Zhou T, Zhan J, Hong S, et al. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep, 2015, 5: 10481.
|
9. |
Zhang C, Jia Y, Jia Y, et al. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer. Int J Clin Oncol, 2018, 23(6): 1070-1075.
|
10. |
Jiang X, Mei X, Wu H, et al. D-dimer level is related to the prognosis of patients with small cell lung cancer. Ann Transl Med, 2017, 5(20): 394.
|
11. |
Shen M, Hu P, Donskov F, et al. Tumor-associated neutropils as a new prognostic factor in cancer: A systematic review and meta-analysis. PLoS One, 2014, 9(6): e98259.
|
12. |
Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm, 2016, 2016: 6058147.
|
13. |
Sionov RV, Assi S, Gershkovitz M, et al. Isolation and characterization of neutrophils with anti- tumor propertier. J Vis Exp, 2015, 19(100): e52933.
|
14. |
Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res, 2016, 4(2): 83-91.
|
15. |
Li Z, Takino T, Endo Y, et al. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis. Cancer Sci, 2017, 108(3): 347-353.
|
16. |
Wang SC, Chou JF, Strong VE, et al. Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg, 2016, 263(2): 292-297.
|
17. |
Takahashi Y, Kawamura M, Hato T, et al. Neutrophil-lymphocyte ratio as a prognostic marker for lung adenocarcinoma after complete resection. World J Surg, 2016, 40(2): 365-372.
|
18. |
Grenader T, Waddell T, Peckitt C, et al. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: Exploratory analysis of the REAL-2 trial. Ann Oncol, 2016, 27(4): 687-692.
|
19. |
Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature, 2013, 501(7467): 346-354.
|
20. |
曹雪涛, 主编. 医学免疫学. 北京: 人民卫生出版社, 2016. 83-92.
|
21. |
Zhao L, Li T, Yang Y, et al. Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin ®—Activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer. Immunotherapy, 2019, 11(4): 273-282.
|
22. |
Wang J, Kalhor N, Hu J, et al. Pretreatment neutrophil to lymphocyte ratio is associated with poor survival in patients with stage Ⅰ-Ⅲ non-small cell lung cancer. PLoS One, 2016, 11(10): e0163397.
|
23. |
Suh KJ, Kim SH, Kim YJ, et al. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody. Cancer Immunol Immunother, 2018, 67(3): 459-470.
|
24. |
Yan M, Jurasz P. The role of platelets in the tumor microenvironment: From solid tumors to leukemia. Biochim Biophys Acta, 2016, 1863(3): 392-400.
|
25. |
孙文兵, 孔健. 血小板在肿瘤进展中的作用. 医学研究杂志, 2016, 45(1): 1-3.
|
26. |
Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell, 2011, 20(5): 576-590.
|
27. |
Qi C, Li B, Guo S, et al. P-selectin-mediated adhesion between platelets and tumor cells promotes intestinal tumorigenesis in Apc(Min/+) mice. Int J Biol Sci, 2015, 11(6): 679-687.
|
28. |
Battinelli EM, Markens BA, Kulenthirarajan RA, et al. Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood, 2014, 123(1): 101-112.
|
29. |
Lal I, Dittus K, Holmes CE. Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res, 2013, 15(4): 207.
|
30. |
Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res, 2009, 69(19): 7775-7783.
|
31. |
Shen XB, Wang Y, Shan BJ, et al. Prognostic significance of platelet-to-lymphocyte ratio (PLR) and mean platelet volume (MPV) during etoposide-based first-line treatment in small cell lung cancer patients. Cancer Manag Res, 2019, 11: 8965-8975.
|
32. |
Sakin A, Sahin S, Yasar N, et al. The relation between hemogram parameters and survival in extensive-stage small cell lung cancer. Oncol Res Treat, 2019, 42(10): 506-515.
|
33. |
Zhang Q, Qu Y, Liu H, et al. Initial platelet-to-lymphocyte count as prognostic factor in limited-stage small cell lung cancer. Biomark Med, 2019, 13(4): 249-258.
|
34. |
王彦, 徐文颖, 蒲俊栏, 等. 治疗前淋巴细胞/单核细胞比值与中国食管鳞癌患者预后关系的 Meta 分析. 医学研究杂志, 2020, 49(1): 128-132, 117.
|
35. |
Wu P, Wu D, Zhao L, et al. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: A meta-analysis. Oncotarget, 2016, 7(26): 40451-40460.
|
36. |
Go S, Kim R, Song H, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer. Med Oncol, 2014, 31(12): 323.
|
37. |
Elsberger B, Lankston L, McMillan DC, et al. Presence of tumoural C-reactive protein correlates with progressive prostate cancer. Prostate Cancer Prostatic Dis, 2011, 14(2): 122-128.
|
38. |
陈冲, 葛鹏, 白银鹏, 等. CRP/Alb 比值对肺癌患者预后的临床价值. 检验医学, 2017, 32(3): 173-177.
|
39. |
Demir S. Role of sterile pyuria in association to elevated PSA values in the diagnosis of non-palpable prostate cancer? Arch Ital Urol Androl, 2019, 91(3): 167.
|
40. |
Rocha P, Morgan CJ, Templeton AJ, et al. Prognostic impact of C-reactive protein in metastatic prostate cancer: A systematic review and meta-analysis. Oncol Res Treat, 2014, 37(12): 772-776.
|
41. |
Leuzzi G, Galeone C, Gisabella M, et al. Baseline C-reactive protein level predicts survival of early-stage lung cancer: Evidence from a systematic review and meta-analysis. Tumori, 2016, 102(5): 441-449.
|
42. |
Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin. Blood Transfus, 2013, 11(4): s18-s25.
|
43. |
Castell JV, Gómez-Lechón MJ, David M, et al. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology, 1990, 12(5): 1179-1186.
|
44. |
Li J, Cheng Y, Liu G, et al. The association of pretreatment serum albumin with outcomes in bladder cancer: A meta-analysis. Onco Targets Ther. 2018 Jun 15; 11: 3449-3459.
|
45. |
Ge L, Wang F. Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: A systematic review and dose-response meta-analysis of observational studies. Cancer Manag Res, 2018, 10: 815-825.
|
46. |
邓梅毓, 赵建清. 血浆 D-二聚体与肺癌分期、病理类型及预后相关性研究. 河北北方学院学报(自然科学版), 2020, 8: 5-7.
|
47. |
Fan S, Zhao G, An G. High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer. J Int Med Res, 2019, 47(1): 215-224.
|